Selective Enzymatic Hydrolysis of Peptide C-Terminal Esters

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for removing C-terminal tert-butyl esters in peptide synthesis are not generally applicable, especially for industrial-scale processes, and existing enzymatic methods have limitations due to endopeptidase activity and solubility issues, which hinder efficient peptide synthesis.

Innovation Solution

The use of protease subtilisin for selective enzymatic hydrolysis of C-terminal tert-butyl esters in peptide substrates, which suppresses endopeptidase activity and allows for high yields, enabling efficient peptide synthesis in both solution-phase and solid-phase methods.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If chemical deprotection methods are used for C-terminal tert-butyl esters, then deprotection can be achieved, but side reactions occur including diketopiperazine formation and loss of enantiomeric integrity

Engineering Contradiction:
Improvedeprotection reliabilityVSAvoidside reactions
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent replaces chemical deprotection methods with enzymatic hydrolysis using proteases. Instead of using chemical reagents that cause side reactions, the invention employs biological enzymes (proteases such as subtilisin, thermolysin, or papain) to selectively hydrolyze the C-terminal tert-butyl ester bond. This substitution of chemical mechanisms with biological catalysis eliminates harmful side reactions like diketopiperazine formation while maintaining high stereoselectivity and deprotection efficiency.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Manufacturing precision

If lipases or esterases are used for tert-butyl ester removal, then selective deprotection is achieved, but endopeptidase activity may still occur with proteases

Engineering Contradiction:
Improvedeprotection selectivityVSAvoidendopeptidase activity
Core Design Contradiction:
Manufacturing precisionVSObject-generated harmful factors

Solution Approach 1:

The patent exploits the local structural features of the substrate to achieve selective deprotection. By designing the peptide substrate with specific characteristics (such as Proline at the penultimate position or specific amino acid sequences), the invention creates a local environment that favors ester hydrolysis over peptide bond hydrolysis. The protease enzyme recognizes and acts preferentially on the ester bond at the C-terminus due to the specific local structure, while leaving the peptide bonds intact, thus achieving high selectivity without endopeptidase activity.

Inventive Principle:
Principle #3Local quality

3Productivity

If convergent synthesis is used for longer peptides, then overall yield increases and synthesis time decreases, but selective C-terminal deprotection becomes more critical and difficult

Engineering Contradiction:
Improvesynthesis efficiencyVSAvoiddeprotection complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent employs a universal enzymatic deprotection system using proteases that can handle diverse peptide substrates in convergent synthesis. The same enzyme system (proteases such as subtilisin, thermolysin, or papain) can deprotect C-terminal tert-butyl esters across different peptide fragments regardless of their specific sequences or lengths. This universality simplifies the convergent synthesis process by providing a single, reliable deprotection method that works for all fragments, eliminating the need for fragment-specific deprotection protocols and reducing overall process complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

4Stability of the object's composition

If primary esters like methyl esters are used for C-terminal protection, then protection is effective, but diketopiperazine formation occurs during deprotection

Engineering Contradiction:
Improveprotection stabilityVSAvoiddiketopiperazine formation
Core Design Contradiction:
Stability of the object's compositionVSObject-generated harmful factors

Solution Approach 1:

The patent replaces chemical deprotection mechanisms with enzymatic hydrolysis to eliminate diketopiperazine formation. Instead of using chemical bases or acids that can promote intramolecular cyclization to form diketopiperazines, the invention employs proteases that selectively hydrolyze the ester bond through a different mechanistic pathway. The enzymatic catalysis proceeds through an acyl-enzyme intermediate that prevents the formation of the cyclic diketopiperazine structure, thereby maintaining product purity while effectively removing the C-terminal protecting group.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This process achieves high to quantitative yields of hydrolyzed products while minimizing endopeptidase activity, making it suitable for convergent peptide syntheses and scalable industrial processes.

Implementation Method 1

selective enzymatic hydrolysis of C-terminal tert-butyl esters of peptide substrates

Methodology Applied
Scientific EffectEnzymatic hydrolysis: Hydrolysis

Implementation Method 2

The use of protease subtilisin for selective enzymatic hydrolysis

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Data Source

PatentEP1979370B1SELECTIVE ENZYMATIC HYDROLYSIS OF C-TERMINAL tert-BUTYL ESTERS OF PEPTIDES
Publication Date: 2010.03.17 NV ORGANON

AI summary

The present invention relates to a process for the selective enzymatic hydrolysis of C-terminal esters of peptide substrates in the synthesis of peptides, comprising hydrolysing C-terminal tert-butyl esters using the protease subtilisin. This process is useful in the production of protected or unprotected peptides.